DarshanTalks Podcast
A podcast by Darshan Kulkarni
406 Episoade
-
Breaking Down GCP E6(R3)
Publicat: 28.01.2025 -
AdvaMed 7 rules for Essential AI Innovation
Publicat: 25.01.2025 -
Teva’s Case Should Shape Your Pharma Strategy
Publicat: 22.01.2025 -
🔒 AI’s Impact on Healthcare: Liability, Ethics, and Responsibility
Publicat: 21.01.2025 -
Four Types of Research related Grant Fraud
Publicat: 18.01.2025 -
Defining Scope in Due Diligence Transactions
Publicat: 17.01.2025 -
Clinical Trial Checklist
Publicat: 16.01.2025 -
Presidential Changes and Impact on Drug Related Misinformation
Publicat: 14.01.2025 -
Prep for Selling Your Company!
Publicat: 12.01.2025 -
Top Tips for Starting a Clinical Trial Site
Publicat: 10.01.2025 -
When Drug Reps Visit: Darshan Reacts
Publicat: 09.01.2025 -
Is Pfizer competing with your pharmacy?
Publicat: 08.01.2025 -
Talking to a Functional Medicine Doctor
Publicat: 07.01.2025 -
Four Types of Research related Grant Fraud
Publicat: 05.01.2025 -
🔒 Leveraging AI and RWD to Reshape Drug Trials!
Publicat: 03.01.2025 -
DCTs in Oncology: Can They Work?
Publicat: 01.01.2025 -
Marketing Due Diligence in Stem cell M&A Transactions
Publicat: 31.12.2024 -
Why Are PBMs Blocking Your Meds? - Darshan reacts
Publicat: 30.12.2024 -
Misleading Ads: Ad laws and Consumer Protection for Marketers
Publicat: 28.12.2024 -
5 Common Clinical Trial Site Failures
Publicat: 26.12.2024
Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
